We had relatively high rates of chemotherapy among patients, a reason for this may be that according to the NCCN guidelines [32], all patients who have a hormone receptor positive and a HER2 overexpression negative status, with negative lymph nodes and a tumor size of > 5 mm should either have the oncotype test or should receive chemotherapy. Here, ERBB2 is linked to neoplasm.